Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3068% below fair value
$3.86−0.31 (-7.43%)
Close on Nov 12, 2026Market cap $72.56MP/E –Yield –
Outset Medical operating margin
Operating margin is operating income as a percentage of revenue.
Outset Medical's operating margin for the twelve months ending Sep 30, 2026 was -51.2%. For fiscal 2025 it was -55.8%, against -99.7% the year before. The highest annual figure on record is -55.8% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -55.8% | +43.9 |
| FY2024 | Dec 31, 2024 | -99.7% | +30.5 |
| FY2023 | Dec 31, 2023 | -130.2% | +9.3 |
| FY2022 | Dec 31, 2022 | -139.6% | −12.4 |
| FY2021 | Dec 31, 2021 | -127.2% | +108.0 |
| FY2020 | Dec 31, 2020 | -235.2% | +231.0 |
| FY2019 | Dec 31, 2019 | -466.3% | +1853.7 |
| FY2018 | Dec 31, 2018 | -2320.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -36.5% | +17.2 |
| Q2 FY2026 | Jun 30, 2026 | -49.6% | +4.1 |
| Q1 FY2026 | Mar 31, 2026 | -60.7% | −5.6 |
| Q4 FY2025 | Dec 31, 2025 | -61.1% | +13.1 |
| Q3 FY2025 | Sep 30, 2025 | -53.7% | +29.4 |
| Q2 FY2025 | Jun 30, 2025 | -53.7% | +58.6 |
| Q1 FY2025 | Mar 31, 2025 | -55.1% | +75.9 |
| Q4 FY2024 | Dec 31, 2024 | -74.2% | +48.3 |
| Q3 FY2024 | Sep 30, 2024 | -83.2% | +66.5 |
| Q2 FY2024 | Jun 30, 2024 | -112.3% | +8.3 |
| Q1 FY2024 | Mar 31, 2024 | -131.0% | −1.1 |
| Q4 FY2023 | Dec 31, 2023 | -122.4% | +2.0 |
| Q3 FY2023 | Sep 30, 2023 | -149.7% | −2.0 |
| Q2 FY2023 | Jun 30, 2023 | -120.6% | +53.8 |
| Q1 FY2023 | Mar 31, 2023 | -129.9% | −10.5 |
| Q4 FY2022 | Dec 31, 2022 | -124.4% | +20.5 |
| Q3 FY2022 | Sep 30, 2022 | -147.7% | −33.2 |
| Q2 FY2022 | Jun 30, 2022 | -174.5% | −55.9 |
| Q1 FY2022 | Mar 31, 2022 | -119.4% | +10.1 |
| Q4 FY2021 | Dec 31, 2021 | -144.9% | +38.4 |
| Q3 FY2021 | Sep 30, 2021 | -114.5% | +181.6 |
| Q2 FY2021 | Jun 30, 2021 | -118.6% | +93.5 |
| Q1 FY2021 | Mar 31, 2021 | -129.5% | +151.6 |
| Q4 FY2020 | Dec 31, 2020 | -183.3% | +78.8 |
| Q3 FY2020 | Sep 30, 2020 | -296.1% | +405.4 |
| Q2 FY2020 | Jun 30, 2020 | -212.1% | – |
| Q1 FY2020 | Mar 31, 2020 | -281.1% | – |
| Q4 FY2019 | Dec 31, 2019 | -262.1% | – |
| Q3 FY2019 | Sep 30, 2019 | -701.5% | – |
See a number that looks wrong?